tetano
Editor, Senior Moderator
Am J Trop Med Hyg
. 2021 Apr 20;tpmd210229.
doi: 10.4269/ajtmh.21-0229. Online ahead of print.
Inactivation of SARS-CoV-2 Laboratory Specimens
Elaine Haddock[SUP] 1 [/SUP], Friederike Feldmann[SUP] 2 [/SUP], W Lesley Shupert[SUP] 1 [/SUP], Heinz Feldmann[SUP] 1 [/SUP]
Affiliations
Abstract
The burden on diagnostic and research laboratories to provide reliable inactivation for biological specimens to allow for safe downstream processing is high during the coronavirus disease 2019 (COVID-19) pandemic. We provide safety data regarding commonly used chemical and physical inactivation procedures that verify their effectiveness against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
. 2021 Apr 20;tpmd210229.
doi: 10.4269/ajtmh.21-0229. Online ahead of print.
Inactivation of SARS-CoV-2 Laboratory Specimens
Elaine Haddock[SUP] 1 [/SUP], Friederike Feldmann[SUP] 2 [/SUP], W Lesley Shupert[SUP] 1 [/SUP], Heinz Feldmann[SUP] 1 [/SUP]
Affiliations
- PMID: 33878029
- DOI: 10.4269/ajtmh.21-0229
Abstract
The burden on diagnostic and research laboratories to provide reliable inactivation for biological specimens to allow for safe downstream processing is high during the coronavirus disease 2019 (COVID-19) pandemic. We provide safety data regarding commonly used chemical and physical inactivation procedures that verify their effectiveness against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).